Moreover, the BUN to ALB ratio (BAR), a novel biomarker integrating the characteristics of BUN and ALB, reflects the nutritional and inflammatory status of the body and has been demonstrated to be a reliable independent prognostic predictor in various diseases, including sepsis, chronic heart failure, and pulmonary embolism (12–14). This evidence concerns the gene ALB and pulmonary embolism.